Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
The Biochemical Journal|July 23, 2015
A unique serpin P1' glutamate and a conserved β-sheet C arginine are key residues for activity, protease recognition and stability of serpinA12 (vaspin)David Ulbricht, Jan Pippel, Stephan Schultz, et al.Bioinformatics Advances|January 26, 2023
ProteinPrompt: a webserver for predicting protein-protein interactionsSebastian Canzler, Markus Fischer, David Ulbricht, et al.Biological Chemistry|March 2, 2018
Kallikrein-related peptidase 14 is the second KLK protease targeted by the serpin vaspinDavid Ulbricht, Catherine A Tindall, Kathrin Oertwig, et al.The Journal of Biological Chemistry|December 13, 2016
Basic Residues of β-Sheet A Contribute to Heparin Binding and Activation of Vaspin (Serpin A12)David Ulbricht, Kathrin Oertwig, Kristin Arnsburg, et al.Biochimica Et Biophysica Acta. Proteins and Proteomics|July 3, 2017
Glycosylation of human vaspin (SERPINA12) and its impact on serpin activity, heparin binding and thermal stabilityKathrin Oertwig, David Ulbricht, Stefanie Hanke, et al.Molecules (Basel, Switzerland)|April 30, 2020
Membrane Phospholipids and Polyphosphates as Cofactors and Binding Molecules of SERPINA12 (vaspin)Catherine A Tindall, Sebastian Dommel, Veronika Riedl, et al.Biological Chemistry|November 4, 2015
Crystal structure of cleaved vaspin (serpinA12)Jan Pippel, E Bartholomeus Kuettner, David Ulbricht, et al.Science Advances|September 23, 2022
Rhomboid-catalyzed intramembrane proteolysis requires hydrophobic matching with the surrounding lipid bilayerOskar Engberg, David Ulbricht, Viola Döbel, et al.Journal of Medicinal Chemistry|May 7, 2020
Structural Studies on the Inhibitory Binding Mode of Aromatic Coumarinic Esters to Human Kallikrein-Related Peptidase 7Stefanie Hanke, Catherine A Tindall, Jan Pippel, et al.Optics Express|June 13, 2014
Three-dimensional organic microlasers with low lasing thresholds fabricated by multiphoton and UV lithographyVincent W Chen, Nina Sobeshchuk, Clément Lafargue, et al.Pageof 1